Article
ROS Deficiency Exacerbates Donor T Cell-mediated hyperacuteGVHD And Its Predictive Value in Allogeneic HSCT in Human Patients.
2022-01-28
Abstract excerpt
<h4>Background: </h4> Hyperacute graft-versus-host disease (GVHD) as a severe and lethal disorder frequently occurs within 2 weeks followed by allogeneic haematopoietic stem-cell transplantation (allo-HSCT). Molecular mechanisms underlying allo-HSCT triggered hyperacute GVHD remain elusive. <h4>Method: </h4> Using a genetic NADPH-oxidase deficient CGD murine hyperacute GVHD model, we measured the proportion and re...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f5bf595a-fb2b-5f68-94ad-d20db13b1320
- DOI
- 10.21203/rs.3.rs-1295930/v1
